Other: Fed Circuit mandate | Aug 23, 2024 | PAPER | BOARD |
Patent Owner's Notice of Appeal | Mar 12, 2024 | PAPER | PATENT OWNER |
JUDGMENT Final Written Decision Denying in Part, Granting in Part, and Dismissing in Part Petitioner’s Motion to Exclude Evidence, Denying in Part and Dismissing in Part Patent Owner’s Motion to Exclude Evidence, Determining Challenged Claims 1, 3–11, 13, 14, 16–24, and 26 Unpatentable 35 U.S.C. § 318(a) | Jan 9, 2024 | PAPER | BOARD |
Petitioner's Amended Mandatory Notices | Dec 20, 2023 | PAPER | PETITIONER |
Petitioner's Amended Mandatory Notices | Nov 29, 2023 | PAPER | PETITIONER |
Other: Hearing transcript | Nov 27, 2023 | PAPER | BOARD |
Patent Owner's Amended Mandatory Notices | Nov 16, 2023 | PAPER | PATENT OWNER |
Order: ORDER Granting Patent Owner’s Unopposed Motion for Entry of Default Protective Order 37 C.F.R. § 42.54 | Oct 27, 2023 | PAPER | BOARD |
Patent Owner's Corrected Statement of Objections to Petitioner's Demonstratives | Oct 24, 2023 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Oct 24, 2023 | PAPER | PATENT OWNER |
Ex. 2351 - Patent Owner's Updated Demonstratives | Oct 24, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Statement of Objections to Petitioner's Demonstratives | Oct 23, 2023 | PAPER | PATENT OWNER |
Petitioner's Statement of Objections to Patent Owner's Demonstratives | Oct 23, 2023 | PAPER | PETITIONER |
Patent Owner's Updated Exhibit List | Oct 20, 2023 | PAPER | PATENT OWNER |
Ex. 2350 - Patent Owner's Demonstratives | Oct 20, 2023 | EXHIBIT | PATENT OWNER |
Petitioner's Updated Exhibit List | Oct 20, 2023 | PAPER | PETITIONER |
Ex. 1173 - Petitioner's Demonstratives | Oct 20, 2023 | EXHIBIT | PETITIONER |
Petitioner's Reply to PO's Opposition to Motion to Exclude | Oct 4, 2023 | PAPER | PETITIONER |
Patent Owner's Reply to Opposition to Motion to Exclude | Oct 4, 2023 | PAPER | PATENT OWNER |
Order: Setting Oral Argument - 37 CFR 42.70 | Sep 27, 2023 | PAPER | BOARD |
Patent Owner's Opposition to Petitioner's Motion to Exclude Evidence | Sep 27, 2023 | PAPER | PATENT OWNER |
Ex. 2349 - Transcript of Deposition of Jeffrey Spada | Sep 27, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Exhibit List | Sep 27, 2023 | PAPER | PATENT OWNER |
Petitioner's Opposition to Patent Owner's Motion to Exclude | Sep 27, 2023 | PAPER | PETITIONER |
Exhibit 3002 | Sep 26, 2023 | EXHIBIT | BOARD |
Petitioner's Motion to Seal | Sep 20, 2023 | PAPER | PETITIONER |
Petitioner's Motion to Exclude Evidence - CONFIDENTIAL | Sep 20, 2023 | PAPER | PETITIONER |
Patent Owner's Motion to Exclude | Sep 20, 2023 | PAPER | PATENT OWNER |
Petitioner's Motion to Exclude Evidence - REDACTED | Sep 20, 2023 | PAPER | PETITIONER |
ORDER Granting Patent Owner’s Motions for Admission Pro Hac Vice of Daralyn J. Durie | Sep 18, 2023 | PAPER | BOARD |
Patent Owner's Motion for Pro Hac Vice Admission of Daralyn Durie | Sep 12, 2023 | PAPER | PATENT OWNER |
Ex. 2348 - Declaration of Daralyn Durie | Sep 12, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Power of Attorney | Sep 12, 2023 | PAPER | PATENT OWNER |
Patent Owner's Amended Mandatory Notices | Sep 12, 2023 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Sep 12, 2023 | PAPER | PATENT OWNER |
Patent Owner's Request for Oral Argument | Aug 30, 2023 | PAPER | PATENT OWNER |
Petitioners' Request for Oral Argument | Aug 30, 2023 | PAPER | PETITIONER |
Petitioner's Fourth Objections to Patent Owner's Exhibits | Aug 16, 2023 | PAPER | PETITIONER |
Patent Owner's Sur-Reply | Aug 9, 2023 | PAPER | PATENT OWNER |
Ex. 2346 [CONFIDENTIAL] Transcript of Deposition of Ivan Hofmann, July 13, 2023 | Aug 9, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2346 [REDACTED] Transcript of Deposition of Ivan Hofmann, July 13, 2023 | Aug 9, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2347 - Transcript of Deposition of Thomas Albini, July 20, 2023 | Aug 9, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion to Seal | Aug 9, 2023 | PAPER | PATENT OWNER |
Patent Owner's Amended Notice of Deposition of Ivan T. Hofmann, C.P.A., C.F.F., C.L.P. | Jul 7, 2023 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Dr. Thomas A. Albini | Jul 7, 2023 | PAPER | PATENT OWNER |
Patent Owner's Second Set of Objections to Petitioner's Exhibits | Jul 6, 2023 | PAPER | PATENT OWNER |
Notice of Deposition of Ivan T. Hofmann | Jul 3, 2023 | PAPER | PATENT OWNER |
Ex. 1127 - '598 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1128 - '791 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1129 - '803 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1130 - '737 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1131 - '842 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1132 - '226 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1133 - '992 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1134 - '345 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1135 - '458 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1136 - '865 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1137 - '572 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1138 - Collaboration Agreement | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1139 - Regeneron 2004 10-K | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1140 - Regeneron 2013 10-Q | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1141 - Purple Book List | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1142 - United Healthcare - Ophthalmologic-VEGF-inhibitors | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1143 - BCBS Florida VEGF | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1144 - Eylea Summary Review | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1145 - mygoodays.org CDF | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1146 - mygooddays.org Assistance Types | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1147 - Official EYLEA (aflibercept) Injection Website | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1148 - '748 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1149 - Bayer and Regeneron to Collaborate on VEGF Trap | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1150 - Complaint, Horizon v. Regeneron, 2022-04 | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1151 - U.S. Statement of Facts (1 of 9) | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1151 - U.S. Statement of Facts (2 of 9) | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1151 - U.S. Statement of Facts (3 of 9) | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1151 - U.S. Statement of Facts (4 of 9) | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1151 - U.S. Statement of Facts (5 of 9) | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1151 - U.S. Statement of Facts (6 of 9) | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1151 - U.S. Statement of Facts (7 of 9) | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1151 - U.S. Statement of Facts (8 of 9) | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1151 - U.S. Statement of Facts (9 of 9) | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1152 - oig.hhs.gov Publication of OIG Special Fraud Alerts | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1153 - MorganLewis - New Purple Book Patent Requirements | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1154 - Fierce Pharma – JPM23 | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1155 - Accord case | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1156 - Regeneron Stip. | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1157 - Medicare Comment Summary | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1158 - '563 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1159 - '653 patent | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1160 - Lucentis EMA | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1161 - Optometry Pharma | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1162 - Fauser | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1163 - Do | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1164 - Batta | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1165 - Stewart 2008 | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1167 - Gerritsen Reply Decl (IPR2022-01225) | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1168 - PAT Survey 2010 | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1169 - Dadgostar | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1170 - CATT Study | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1171 - NCT00685854 (May 24 2008) | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1172 - MACTEL Study Wayback Machine | Jun 29, 2023 | EXHIBIT | PETITIONER |
Ex. 1115 - Hofmann Reply Decl (IPR2022-01225) [REDACTED] | Jun 29, 2023 | EXHIBIT | PETITIONER |
Petitioner Reply (IPR2022-01225) - REDACTED | Jun 29, 2023 | PAPER | PETITIONER |
Petitioner Reply (IPR2022-01225) - CONFIDENTIAL | Jun 29, 2023 | PAPER | PETITIONER |
Ex. 1166 - Bhisitkul & Stewart 2010 | Jun 29, 2023 | EXHIBIT | PETITIONER |
Petitioner Motion to Seal | Jun 28, 2023 | PAPER | PETITIONER |
Ex. 1107 - Albini Reply Decl (IPR2022-01225) | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1108 - Klibanov Tr. [CONFIDENTIAL] | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1108 - Klibanov Tr. [REDACTED] | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1109 - Do Tr. [CONFIDENTIAL] | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1109 - Do Tr. [REDACTED] | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1110 - Brown Tr. | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1111 - Joint Stip. | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1112 - Markman Order | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1113 - WHO Drug Info | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1114 - Hofmann CV | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1115 - Hofmann Reply Decl (IPR2022-01225) [CONFIDENTIAL] | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1116 - ASRS Clinical Update | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1117 - Drugs@FDA_ Eylea | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1118 - Regeneron 2005 10-K | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1119 - Regeneron 2011 10-K | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1120 - Manning 5.4.22 Tr. [REDACTED] | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1120 - Manning 5.4.22 Tr. [CONFIDENTIAL] | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1121 - Manning Tr. [REDACTED] | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1121 - Manning Tr. [CONFIDENTIAL] | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1122 - Eylea Label 02.2023 | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1123 - Eylea Patent List | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1124 - 2020-06-24 Complaint | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1125 - Eylea Label 05.2016 | Jun 28, 2023 | EXHIBIT | PETITIONER |
Ex. 1126 - ’261 patent | Jun 28, 2023 | EXHIBIT | PETITIONER |
Petitioner's Amended Mandatory Notices | May 18, 2023 | PAPER | PETITIONER |
Dr. Manning Notice of Deposition | May 18, 2023 | PAPER | PETITIONER |
Notice of Deposition of Jennifer Colyer | May 10, 2023 | PAPER | PETITIONER |
Notice of Deposition of Jeffrey Spada | May 10, 2023 | PAPER | PETITIONER |
Notice of Deposition of Dr. Diana Do | May 10, 2023 | PAPER | PETITIONER |
Dr. Klibanov Notice of Deposition | May 4, 2023 | PAPER | PETITIONER |
Dr. Brown Notice of Deposition | May 4, 2023 | PAPER | PETITIONER |
Petitioner's Third Objections to Patent Owner's Exhibits | May 3, 2023 | PAPER | PETITIONER |
Patent Owner's Amended Mandatory Notices | May 3, 2023 | PAPER | PATENT OWNER |
Petitioner's Second Objections to Patent Owner's Exhibits | Apr 12, 2023 | PAPER | PETITIONER |
Petitioner's Amended Mandatory Notices | Apr 10, 2023 | PAPER | PETITIONER |
Patent Owner's Motion to Seal | Apr 5, 2023 | PAPER | PATENT OWNER |
Patent Owner Response [CONFIDENTIAL] | Apr 5, 2023 | PAPER | PATENT OWNER |
Patent Owner Response [REDACTED] | Apr 5, 2023 | PAPER | PATENT OWNER |
Ex. 2055 - Brown Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2056 - [CONFIDENTIAL] Do Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2056 - [REDACTED] Do Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2057 - [CONFIDENTIAL] Klibanov Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2057 - [REDACTED] Klibanov Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2058 - Manning Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2059 - [CONFIDENTIAL] Manning Declaration from IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2059 - [REDACTED] Manning Declaration from IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2060 - Brown CV | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2061 - Klibanov CV | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2062 - Excerpts from Shorter Oxford English Dictionary | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2063 - Eylea Prescribing Information | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2064 - Eylea Approval Letter | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2065 - Biochemistry 2002 5 ed | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2066 - Organic Chemistry 4th ed Chap 27 - Part 1 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2066 - Organic Chemistry 4th ed Chap 27 - Part 2 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2067 - Hirokawa 1988 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2068 - Prange 1998 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2069 - Mihailescu 2001 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2070 - Beek 2002 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2071 - Handgraaf 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2072 - Yu 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2073 - Scott 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2074 - Kleiger 2000 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2075 - Demarest 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2076 - Cantu 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2077 - Biochemistry 6th ed Chap 7 - Part 1 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2077 - Biochemistry 6th ed Chap 7 - Part 2 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2078 - Davis-Smyth 1996 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2079 - UNIPROT - P17948 VGFR1 Human | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2080 - UNIPROT - P17948 v140 -2011-01-11 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
EX. 2081 - Weissmann 1997 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2082 - Lu 2000 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2083 - Franklin 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2084 - UNIPROT - P35968 VGFR2 Human | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2085 - UNIPROT - P35968 v127 -2011-01-11 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2086 - Bowie 1990 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2087 - US Pub 2006_0058234 A1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2088 - lacono 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2089 - Stewart & Rosenfeld 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2090 - Do 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2091 - Moroney 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2092 - US Pub 2010_0160233 A1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2093 - Hachiya 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2094 - Piques 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2095 - WO 2000_075319 A1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2096 - Kuhlmann 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2097 - Murphy 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2098 - [CONFIDENTIAL] Zaltrap non-comparability | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2099 - Bork 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2100 - Sola 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2101 - [CONFIDENTIAL] Koehler-Stec Report | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2102 - Wells 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2103 - [CONFIDENTIAL] REGN Research Collaboration Agreement Template | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2104 - [CONFIDENTIAL] Marmoset Pregnancy Study Email | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2106 - Macugen Approval Letter | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2107 - 2004 Macugen Label | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2108 - NCT00473330 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2109 - Rosenfeld 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2110 - Genentech Press Release Dec. 30, 2005 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2111 - Genentech Press Release June 30, 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2112 - NCT00473330 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2113 - NCT00473382 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2114 - NCT00486018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2115 - NCT00485836 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2116 - NCT00943072 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2117 - NCT01012973 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2118 - FDA Non-Inferiority Clinical Trials | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2119 - May 2016 Eylea Label | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2120 - Am Acad Opthalmolgy - Sect 9, Chap 6 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2121 - Jaffe 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2122 - [CONFIDENTIAL] VGFT-OD-0605 Analysis Summary | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2123 - NCT00826618 (2009 version) | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2124 - Albini & Davis 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2125 - NCT00826618 (2014 version ) | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2126 - BenEzra 2005 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2127 - Ramirez 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2128 - Adamis Chapter 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2129 - Brown 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2130 - Gragoudas 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2131 - Regillo 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2132 - Levine 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2134 - Regeneron Earnings Call Tr Apr 26, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2135 - Regeneron Earnings Call Tr July 25, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2136 - Eylea Marketing Material, 2013 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2138 - [CONFIDENTIAL] Regeneron Physician ATU Wave 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2139 - Regeneron For the Treatment of Wet AMD, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2140 - [CONFIDENTIAL] Regeneron Physician ATU Wave 5 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2141 - Am. Acad. of Ophthalmol. - Anti-VEGF Treatments | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2142 - Am. Acad. of Ophthalmol. - Bevacizumab | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2143 - Am. Acad. of Ophthalmol. - Ophthalmology Subspecialists | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2144 - Am. Acad. of Ophthalmol. - Retinal Vasculitis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2145 - Am. Acad. of Ophthalmol. - What Is Avastin | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2146 - Am. Acad. of Ophthalmol. - What Is Eylea | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2147 - Am. Acad. of Ophthalmol. - What Is Lucentis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2148 - Am. Soc. of Retina Specialists - About Us | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2149 - Am. Soc. of Retina Specialists - Age-Related Macular Degeneration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2150 - Am. Soc. of Retina Specialists - Branch Retinal Vein Occlusion | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2151 - Am. Soc. of Retina Specialists - Central Retinal Vein Occlusion | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2152 - Am. Soc. of Retina Specialists - Diabetic Retinopathy | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2153 - Amgen - Fusion Protein | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2154 - ASHA - Calculating Medicare Fee Schedule Rates | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2155 - ASPE Issue Brief - Medicare Part B Reimbursement of Prescription Drugs | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2156 - Avastin Drug Label 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2157 - Base Pair Biotechnologies - What is an Aptamer | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2158 - Bausch and Lomb Website - Visudyne | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2159 - Bausch and Lomb Website - Visudyne Saftey Information | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2160 - Bausch Health Companies 10-K, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2161 - Beovu Drug Label Oct. 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2162 - Beovu Drug Label June 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2163 - [CONFIDENTIAL] Regeneron Physician ATU Wave 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2164 - BrightFocus Foundation - AMD Facts & Figures | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
EXPUNGED | Apr 5, 2023 | PAPER | PATENT OWNER |
Ex. 2165 - Brookings - Medicare Payment for Physician-Administered (Part B) Drugs | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2166 - Calculator.net - Sample Size Calculator | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2167 - CDC - Vision Loss - A Public Health Problem | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2168 - Centers for Medicare & Medicaid Services Data - Practitioners | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 1 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 2 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 3 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 4 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2170 - [CONFIDENTIAL] US Eylea P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2170 - [REDACTED] US Eylea P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2171 - CloudResearch - Determining Sample Size | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2172 - CMS - 2021 ASP Drug Pricing Files | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2173 - CMS - Medicare Part B Drug Average Sales Price | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2174 - CMS - Physician Fee Schedule | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2175 - CMS Medicare Coverage Database - Billing and Coding Afilbercept | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2176 - [CONFIDENTIAL] Regeneron Q4 Performance Update | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2177 - Donahue 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2178 - Donohue 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2179 - Dreyfuss 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2180 - Miller 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2181 - Drugs.com - Eylea FDA Approval History | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2182 - Elyasi 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2183 - Eye Care Surgery Center - Macular Degeneration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2184 - EyeGuru - Intravitreal Injection Standard Dosing Table | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2185 - Eylea Drug Label Nov. 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2186 - Eylea Drug Label Sept. 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2187 - Eylea Drug Label Oct. 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2188 - Eylea Drug Label May 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2189 - Eylea Drug Label Mar. 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2190 - Eylea Website - Dosing Flexibility for Wet AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2191 - FDA Website - Drug Approval Package Macugen | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2192 - FiercePharma - Beovu, Novartis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2193 - FiercePharma - Novartis Drug Beovu Tied to Potential Vision Loss | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2194 - FiercePharma - The top 20 drugs by worldwide sales in 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2195 - FocusVision - Survey Sample Size How Much Do I Need | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2196 - Gagnon 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2197 - [CONFIDENTIAL] Eylea Physician ATU Benchmark Wave | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2198 - GEN - FDA Green-Lights Genentechs Lucentis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2199 - Genentech Press Release June 30, 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2200 - [CONFIDENTIAL] Regeneron US Eylea Historical PL | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2200 - [REDACTED] Regeneron US Eylea Historical PL | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2201 - Guha 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2202 - HCPCS Codes - HCPCS Codes | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2203 - Healio - Access to retina providers shows no geographic bias in US | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2204 - Hopkins Medicine Website - Photodynamic Therapy for AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2205 - [CONFIDENTIAL] Eylea DME Market Assessment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2206 - IQVIA 10-K 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2207 - IQVIA - Available IQVIA Data | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2208 - [CONFIDENTIAL] Eylea ATU Wave 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2209 - KFF - A Snapshot of Sources | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2210 - KFF - Medicare Advantage in 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2211 - Ling 2002 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2212 - Lucentis Drug Label 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2213 - Lucentis Drug Label June 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2214 - Lucentis Drug Label Aug. 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2215 - Lucentis Drug Label Apr. 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2216 - Lucentis Drug Label Mar. 2018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2218 - [CONFIDENTIAL] Eylea Components of Reimbursement | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2218 - [REDACTED] Eylea Components of Reimbursement | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2219 - Mankiw Chapter 1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2220 - Manning 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2221 - Mayo Clinic - Wet macular degeneration - Diagnosis and treatment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2222 - Mayo Clinic - Wet macular degeneration - Symptoms and Causes | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2223 - Medicare Interactive - Medicare Part B Covered Services | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2224 - Medicare Interactive - The parts of Medicare (A, B, C, D) | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2225 - Medicare.gov - Macular Degeneration Coverage | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2226 - Medicare.gov - Medicare Advantage Plans | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2227 - Medicare.gov - When does Medicare coverage start | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2228 - MedlinePlus Medical Encyclopedia - Laser photocoagulation | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2229 - [CONFIDENTIAL] Regeneron WAC Pricing | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2230 - Novartis - Annual Report, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2231 - Novartis Press Release Oct. 8, 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2232 - Novartis Press Release June 11, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2233 - Oct 2012 ASP Pricing File revised 060513 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2234 - Oct 2013 ASP Pricing File updated 060614 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2235 - Oct 2015 ASP Pricing File - updated 120915 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2236 - Oct 2016 ASP Pricing File updated 082817 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2237 - Oct 2017 ASP Pricing File 083017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2238 - Oct 2018 ASP Pricing File updated 052919 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2239 - Oct 2019 ASP Pricing File 052920 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2240 - Oct 2014 ASP Pricing File - revised 090115 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2241 - Oct 2020 ASP Pricing File updated 090121 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2242 - Oct 2021 ASP Pricing File updated 011022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2243 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2244 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2245 - Pindyck Chapter 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2246 - Regeneron - About Us | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2247 - Regeneron Press Release July 29, 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2248 - Regeneron Press Release Oct. 6, 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2249 - Regeneron Press Release May 13, 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2250 - [CONFIDENTIAL] ASRS Prefernces & Trends Survey 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2251 - Regeneron - History | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2252 - Regeneron Press Release Sept. 21, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2253 - Regeneron - Research Areas | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2254 - Regeneron Form 10-K for 2020 - Part 1 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2254 - Regeneron Form 10-K for 2020 - Part 2 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2255 - Retinal Physician - Revisiting an Early Treatment for Wet AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2256 - Roche 10-K, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2257 - Roche Press Release Aug. 13, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2258 - Roche Press Release Apr. 18, 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2259 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2260 - Schweitzer Chapter 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2261 - ScienceDaily - FDA Approves First Angiogenesis Inhibitor | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2262 - Sivaprasad 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2263 - [CONFIDENTIAL] Eylea Sales Summary | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
EXPUNGED | Apr 5, 2023 | PAPER | PATENT OWNER |
Ex. 2264 - Verywell Health - Maclular Degeneration Timeline | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2265 - Vestrum Health - Explore what we can do for you | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2266 - Vestrum Health - Pharmaceutical companies | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2267 - Visudyne Drug Label Apr 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2268 - Weidner 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2269 - WHO - Blindness and vision impairment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2270 - Yahoo Finance - Beovu Now Publicly Reimbursed | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2271 - Yorston 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2272 - [CONFIDENTIAL] Eylea Q2 2021 Performance | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2273 - [CONFIDENTIAL] Vestrum Anti-VEGF Category Sales Shares | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2274 - [CONFIDENTIAL] Eylea Wet AMD Line of Therapy Insights | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2275 - [CONFIDENTIAL] Vestrum Anti-VEGF Market Share Adjustment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2276 - [CONFIDENTIAL] Eylea Q2 2020 Performance | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2277 - [CONFIDENTIAL] Regeneron Marketing Planning Process | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2278 - [CONFIDENTIAL] Regeneron Wave 1 2021 Performance Update | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2279 - Regeneron ATU Sales Share Data - All Indications | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2282 - Regeneron ATU Sales Share Data - CRVO | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2283 - Regeneron ATU Sales Share Data - BRVO | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2284 - Regeneron ATU Sales Share Data - DR without DME | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2285 - [CONFIDENTIAL] Eylea Gross & Net Sales P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2285 - [REDACTED] Eylea Gross & Net Sales P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2286 - Abraham 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2287 - Barbazetto 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2288 - Cruz 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2289 - Retinal Physician Symposium | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2290 - Lucentis Label 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2291 - Schmidt-Erfuth 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2292 - Boyer 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2293 - Margolis 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2294 - Park 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2295 - Spaide 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2296 - Brown 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2297 - Heier 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2298 - [CONFIDENTIAL] Research Agreement | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2299 - [CONFIDENTIAL] VGFT-OD-0605 Protocol Signature Page | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2300 - Eylea P I | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2301 - Regeneron Corrected Press Release Nov. 18, 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2302 - Eylea Approval Letter | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2303 - Bhisitkul & Stewart 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2304 - FDA 22 Case Studies | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2305 - NCT02247531 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2306 - NCT02247479 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2307 - NCT03577899 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2308 - NCT03630952 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2309 - NCT01944839 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2310 - NCT01940900 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2311 - Mathis 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2312 - Cousins 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2313 - Helzner 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2314 - FDA Guidance -Expedited Programs | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2315 - NCT01486771 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2316 - Gallemore 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2317 - Kanghong Press Release - Translation | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2318 - Kanghong Press Release - Chinese | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2319 - Thomas 2013 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2320 - Ohr 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2321 - FDA Approves Eylea for Wet AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2322 - Porter 2018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2323 - Albini Deposition Transcript, Mar. 21, 2023 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2324 - Gerritsen Deposition Transcript, Jan. 14, 2022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2325 - Gerritsen Deposition Transcript, Mar. 17, 2023 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2326 - Albini Depo Ex 14 from Jan. 20, 2022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2327 - Petition for IPR2023-00442 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2328 - Mylan Press Release, Jan. 3, 2018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2329 - [CONFIDENTIAL] Colyer Declaration 681 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2329 - [REDACTED] Colyer Declaration 681 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2332 - Ophthotech Press Release, Dec. 12, 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2333 - Genentech Press Release, Nov. 9, 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2334 - Ciulla & Rosenfeld 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2335 - US Patent No. 9,669,069 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2336 - US Patent No. 7,374,757 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2337 - US Patent No. 7,070,959 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2338 - Gerritsen Reply Declaration, IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2339 - Gerritsen Declaration, IPR2021-00880 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2340 - Gerritsen Reply Declaration, IPR2021-00880 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2341 - Albini Reply Declaration, IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [CONFIDENTIAL] - Hofmann Deposition Transcript, June 23, 2022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [REDACTED] Hofmann Deposition Transcript, June 23, 2022 - Part 1 of 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [REDACTED] Hofmann Deposition Transcript, June 23, 2022 - Part 2 of 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [REDACTED] Hofmann Deposition Transcript, June 23, 2022 - Part 3 of 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2343 - Spada Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
EXPUNGED | Apr 5, 2023 | PAPER | PATENT OWNER |
Ex. 2055 - Brown Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2056 - [CONFIDENTIAL] Do Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2056 - [REDACTED] Do Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2057 - [CONFIDENTIAL] Klibanov Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2057 - [REDACTED] Klibanov Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2058 - Manning Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2059 - [CONFIDENTIAL] Manning Declaration from IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2059 - [REDACTED] Manning Declaration from IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2060 - Brown CV | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2061 - Klibanov CV | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2062 - Excerpts from Shorter Oxford English Dictionary | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2063 - Eylea Prescribing Information | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2064 - Eylea Approval Letter | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2065 - Biochemistry 2002 5 ed | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2066 - Organic Chemistry 4th ed Chap 27 - Part 1 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2066 - Organic Chemistry 4th ed Chap 27 - Part 2 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2067 - Hirokawa 1988 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2068 - Prange 1998 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2069 - Mihailescu 2001 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2070 - Beek 2002 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2071 - Handgraaf 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2072 - Yu 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2073 - Scott 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2074 - Kleiger 2000 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2075 - Demarest 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2076 - Cantu 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2077 - Biochemistry 6th ed Chap 7 - Part 1 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2077 - Biochemistry 6th ed Chap 7 - Part 2 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2078 - Davis-Smyth 1996 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2079 - UNIPROT - P17948 VGFR1 Human | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2080 - UNIPROT - P17948 v140 -2011-01-11 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
EX. 2081 - Weissmann 1997 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2082 - Lu 2000 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2083 - Franklin 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2084 - UNIPROT - P35968 VGFR2 Human | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2085 - UNIPROT - P35968 v127 -2011-01-11 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2086 - Bowie 1990 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2087 - US Pub 2006_0058234 A1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2088 - lacono 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2089 - Stewart & Rosenfeld 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2090 - Do 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2091 - Moroney 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2092 - US Pub 2010_0160233 A1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2093 - Hachiya 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2094 - Piques 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2095 - WO 2000_075319 A1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2096 - Kuhlmann 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2097 - Murphy 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2098 - [CONFIDENTIAL] Zaltrap non-comparability | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2099 - Bork 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2100 - Sola 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2101 - [CONFIDENTIAL] Koehler-Stec Report | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2102 - Wells 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2103 - [CONFIDENTIAL] REGN Research Collaboration Agreement Template | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2104 - [CONFIDENTIAL] Marmoset Pregnancy Study Email | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2106 - Macugen Approval Letter | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2107 - 2004 Macugen Label | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2108 - NCT00473330 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2109 - Rosenfeld 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2110 - Genentech Press Release Dec. 30, 2005 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2111 - Genentech Press Release June 30, 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2112 - NCT00473330 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2113 - NCT00473382 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2114 - NCT00486018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2115 - NCT00485836 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2116 - NCT00943072 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2117 - NCT01012973 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2118 - FDA Non-Inferiority Clinical Trials | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2119 - May 2016 Eylea Label | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2120 - Am Acad Opthalmolgy - Sect 9, Chap 6 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2121 - Jaffe 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2122 - [CONFIDENTIAL] VGFT-OD-0605 Analysis Summary | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2123 - NCT00826618 (2009 version) | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2124 - Albini & Davis 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2125 - NCT00826618 (2014 version ) | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2126 - BenEzra 2005 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2127 - Ramirez 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2128 - Adamis Chapter 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2129 - Brown 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2130 - Gragoudas 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2131 - Regillo 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2132 - Levine 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2134 - Regeneron Earnings Call Tr Apr 26, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2135 - Regeneron Earnings Call Tr July 25, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2136 - Eylea Marketing Material, 2013 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2138 - [CONFIDENTIAL] Regeneron Physician ATU Wave 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2139 - Regeneron For the Treatment of Wet AMD, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2140 - [CONFIDENTIAL] Regeneron Physician ATU Wave 5 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2141 - Am. Acad. of Ophthalmol. - Anti-VEGF Treatments | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2142 - Am. Acad. of Ophthalmol. - Bevacizumab | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2143 - Am. Acad. of Ophthalmol. - Ophthalmology Subspecialists | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2144 - Am. Acad. of Ophthalmol. - Retinal Vasculitis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2145 - Am. Acad. of Ophthalmol. - What Is Avastin | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2146 - Am. Acad. of Ophthalmol. - What Is Eylea | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2147 - Am. Acad. of Ophthalmol. - What Is Lucentis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2148 - Am. Soc. of Retina Specialists - About Us | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2149 - Am. Soc. of Retina Specialists - Age-Related Macular Degeneration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2150 - Am. Soc. of Retina Specialists - Branch Retinal Vein Occlusion | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2151 - Am. Soc. of Retina Specialists - Central Retinal Vein Occlusion | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2152 - Am. Soc. of Retina Specialists - Diabetic Retinopathy | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2153 - Amgen - Fusion Protein | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2154 - ASHA - Calculating Medicare Fee Schedule Rates | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2155 - ASPE Issue Brief - Medicare Part B Reimbursement of Prescription Drugs | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2156 - Avastin Drug Label 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2157 - Base Pair Biotechnologies - What is an Aptamer | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2158 - Bausch and Lomb Website - Visudyne | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2159 - Bausch and Lomb Website - Visudyne Saftey Information | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2160 - Bausch Health Companies 10-K, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2161 - Beovu Drug Label Oct. 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2162 - Beovu Drug Label June 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2163 - [CONFIDENTIAL] Regeneron Physician ATU Wave 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2164 - BrightFocus Foundation - AMD Facts & Figures | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2165 - Brookings - Medicare Payment for Physician-Administered (Part B) Drugs | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2166 - Calculator.net - Sample Size Calculator | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2167 - CDC - Vision Loss - A Public Health Problem | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2168 - Centers for Medicare & Medicaid Services Data - Practitioners | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 1 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 2 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 3 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 4 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2170 - [CONFIDENTIAL] US Eylea P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2170 - [REDACTED] US Eylea P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2171 - CloudResearch - Determining Sample Size | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2172 - CMS - 2021 ASP Drug Pricing Files | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2173 - CMS - Medicare Part B Drug Average Sales Price | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2174 - CMS - Physician Fee Schedule | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2175 - CMS Medicare Coverage Database - Billing and Coding Afilbercept | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2176 - [CONFIDENTIAL] Regeneron Q4 Performance Update | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2177 - Donahue 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2178 - Donohue 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2179 - Dreyfuss 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2180 - Miller 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2181 - Drugs.com - Eylea FDA Approval History | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2182 - Elyasi 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2183 - Eye Care Surgery Center - Macular Degeneration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2184 - EyeGuru - Intravitreal Injection Standard Dosing Table | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2185 - Eylea Drug Label Nov. 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2186 - Eylea Drug Label Sept. 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2187 - Eylea Drug Label Oct. 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2188 - Eylea Drug Label May 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2189 - Eylea Drug Label Mar. 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2190 - Eylea Website - Dosing Flexibility for Wet AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2191 - FDA Website - Drug Approval Package Macugen | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2192 - FiercePharma - Beovu, Novartis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2193 - FiercePharma - Novartis Drug Beovu Tied to Potential Vision Loss | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2194 - FiercePharma - The top 20 drugs by worldwide sales in 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2195 - FocusVision - Survey Sample Size How Much Do I Need | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2196 - Gagnon 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2197 - [CONFIDENTIAL] Eylea Physician ATU Benchmark Wave | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2198 - GEN - FDA Green-Lights Genentechs Lucentis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2199 - Genentech Press Release June 30, 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2200 - [CONFIDENTIAL] Regeneron US Eylea Historical PL | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2200 - [REDACTED] Regeneron US Eylea Historical PL | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2201 - Guha 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2202 - HCPCS Codes - HCPCS Codes | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2203 - Healio - Access to retina providers shows no geographic bias in US | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2204 - Hopkins Medicine Website - Photodynamic Therapy for AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2205 - [CONFIDENTIAL] Eylea DME Market Assessment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2206 - IQVIA 10-K 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2207 - IQVIA - Available IQVIA Data | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2208 - [CONFIDENTIAL] Eylea ATU Wave 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2209 - KFF - A Snapshot of Sources | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2210 - KFF - Medicare Advantage in 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2211 - Ling 2002 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2212 - Lucentis Drug Label 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2213 - Lucentis Drug Label June 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2214 - Lucentis Drug Label Aug. 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2215 - Lucentis Drug Label Apr. 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2216 - Lucentis Drug Label Mar. 2018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2218 - [CONFIDENTIAL] Eylea Components of Reimbursement | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2218 - [REDACTED] Eylea Components of Reimbursement | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2219 - Mankiw Chapter 1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2220 - Manning 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2221 - Mayo Clinic - Wet macular degeneration - Diagnosis and treatment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2222 - Mayo Clinic - Wet macular degeneration - Symptoms and Causes | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2223 - Medicare Interactive - Medicare Part B Covered Services | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2224 - Medicare Interactive - The parts of Medicare (A, B, C, D) | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2225 - Medicare.gov - Macular Degeneration Coverage | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2226 - Medicare.gov - Medicare Advantage Plans | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2227 - Medicare.gov - When does Medicare coverage start | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2228 - MedlinePlus Medical Encyclopedia - Laser photocoagulation | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2229 - [CONFIDENTIAL] Regeneron WAC Pricing | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2230 - Novartis - Annual Report, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2231 - Novartis Press Release Oct. 8, 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2232 - Novartis Press Release June 11, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2233 - Oct 2012 ASP Pricing File revised 060513 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2234 - Oct 2013 ASP Pricing File updated 060614 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2235 - Oct 2015 ASP Pricing File - updated 120915 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2236 - Oct 2016 ASP Pricing File updated 082817 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2237 - Oct 2017 ASP Pricing File 083017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2238 - Oct 2018 ASP Pricing File updated 052919 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2239 - Oct 2019 ASP Pricing File 052920 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2240 - Oct 2014 ASP Pricing File - revised 090115 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2241 - Oct 2020 ASP Pricing File updated 090121 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2242 - Oct 2021 ASP Pricing File updated 011022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2243 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2244 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2245 - Pindyck Chapter 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2246 - Regeneron - About Us | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2247 - Regeneron Press Release July 29, 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2248 - Regeneron Press Release Oct. 6, 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2249 - Regeneron Press Release May 13, 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2250 - [CONFIDENTIAL] ASRS Prefernces & Trends Survey 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2251 - Regeneron - History | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2252 - Regeneron Press Release Sept. 21, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2253 - Regeneron - Research Areas | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2254 - Regeneron Form 10-K for 2020 - Part 1 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2254 - Regeneron Form 10-K for 2020 - Part 2 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2255 - Retinal Physician - Revisiting an Early Treatment for Wet AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2256 - Roche 10-K, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2257 - Roche Press Release Aug. 13, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2258 - Roche Press Release Apr. 18, 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2259 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2260 - Schweitzer Chapter 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2261 - ScienceDaily - FDA Approves First Angiogenesis Inhibitor | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2262 - Sivaprasad 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2263 - [CONFIDENTIAL] Eylea Sales Summary | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2264 - Verywell Health - Maclular Degeneration Timeline | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2265 - Vestrum Health - Explore what we can do for you | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2266 - Vestrum Health - Pharmaceutical companies | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2267 - Visudyne Drug Label Apr 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2268 - Weidner 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2269 - WHO - Blindness and vision impairment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2270 - Yahoo Finance - Beovu Now Publicly Reimbursed | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2271 - Yorston 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2272 - [CONFIDENTIAL] Eylea Q2 2021 Performance | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2273 - [CONFIDENTIAL] Vestrum Anti-VEGF Category Sales Shares | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2274 - [CONFIDENTIAL] Eylea Wet AMD Line of Therapy Insights | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2275 - [CONFIDENTIAL] Vestrum Anti-VEGF Market Share Adjustment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2276 - [CONFIDENTIAL] Eylea Q2 2020 Performance | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2277 - [CONFIDENTIAL] Regeneron Marketing Planning Process | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2278 - [CONFIDENTIAL] Regeneron Wave 1 2021 Performance Update | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2279 - Regeneron ATU Sales Share Data - All Indications | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2282 - Regeneron ATU Sales Share Data - CRVO | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2283 - Regeneron ATU Sales Share Data - BRVO | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2284 - Regeneron ATU Sales Share Data - DR without DME | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2285 - [CONFIDENTIAL] Eylea Gross & Net Sales P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2285 - [REDACTED] Eylea Gross & Net Sales P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2286 - Abraham 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2287 - Barbazetto 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2288 - Cruz 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2289 - Retinal Physician Symposium | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2290 - Lucentis Label 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2291 - Schmidt-Erfuth 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2292 - Boyer 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2293 - Margolis 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2294 - Park 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2295 - Spaide 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2296 - Brown 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2297 - Heier 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2298 - [CONFIDENTIAL] Research Agreement | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2299 - [CONFIDENTIAL] VGFT-OD-0605 Protocol Signature Page | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2300 - Eylea P I | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2301 - Regeneron Corrected Press Release Nov. 18, 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2302 - Eylea Approval Letter | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2303 - Bhisitkul & Stewart 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2304 - FDA 22 Case Studies | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2305 - NCT02247531 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2306 - NCT02247479 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2307 - NCT03577899 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2308 - NCT03630952 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2309 - NCT01944839 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2310 - NCT01940900 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2311 - Mathis 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2312 - Cousins 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2313 - Helzner 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2314 - FDA Guidance -Expedited Programs | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2315 - NCT01486771 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2316 - Gallemore 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2317 - Kanghong Press Release - Translation | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2318 - Kanghong Press Release - Chinese | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2319 - Thomas 2013 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2320 - Ohr 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2321 - FDA Approves Eylea for Wet AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2322 - Porter 2018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2323 - Albini Deposition Transcript, Mar. 21, 2023 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2324 - Gerritsen Deposition Transcript, Jan. 14, 2022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2325 - Gerritsen Deposition Transcript, Mar. 17, 2023 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2326 - Albini Depo Ex 14 from Jan. 20, 2022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2327 - Petition for IPR2023-00442 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2328 - Mylan Press Release, Jan. 3, 2018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2329 - [CONFIDENTIAL] Colyer Declaration 681 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2329 - [REDACTED] Colyer Declaration 681 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2332 - Ophthotech Press Release, Dec. 12, 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2333 - Genentech Press Release, Nov. 9, 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2334 - Ciulla & Rosenfeld 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2335 - US Patent No. 9,669,069 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2336 - US Patent No. 7,374,757 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2337 - US Patent No. 7,070,959 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2338 - Gerritsen Reply Declaration, IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2339 - Gerritsen Declaration, IPR2021-00880 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2340 - Gerritsen Reply Declaration, IPR2021-00880 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2341 - Albini Reply Declaration, IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [CONFIDENTIAL] - Hofmann Deposition Transcript, June 23, 2022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [REDACTED] Hofmann Deposition Transcript, June 23, 2022 - Part 1 of 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [REDACTED] Hofmann Deposition Transcript, June 23, 2022 - Part 2 of 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [REDACTED] Hofmann Deposition Transcript, June 23, 2022 - Part 3 of 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2343 - Spada Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
EXPUNGED | Apr 5, 2023 | PAPER | PATENT OWNER |
Ex. 2055 - Brown Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2056 - [CONFIDENTIAL] Do Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2056 - [REDACTED] Do Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2057 - [CONFIDENTIAL] Klibanov Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2057 - [REDACTED] Klibanov Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2058 - Manning Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2059 - [CONFIDENTIAL] Manning Declaration from IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2059 - [REDACTED] Manning Declaration from IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2060 - Brown CV | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2061 - Klibanov CV | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2062 - Excerpts from Shorter Oxford English Dictionary | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2063 - Eylea Prescribing Information | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2064 - Eylea Approval Letter | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2065 - Biochemistry 2002 5 ed | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2066 - Organic Chemistry 4th ed Chap 27 - Part 1 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2066 - Organic Chemistry 4th ed Chap 27 - Part 2 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2067 - Hirokawa 1988 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2068 - Prange 1998 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2069 - Mihailescu 2001 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2070 - Beek 2002 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2071 - Handgraaf 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2072 - Yu 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2073 - Scott 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2074 - Kleiger 2000 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2075 - Demarest 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2076 - Cantu 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2077 - Biochemistry 6th ed Chap 7 - Part 1 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2077 - Biochemistry 6th ed Chap 7 - Part 2 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2078 - Davis-Smyth 1996 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2079 - UNIPROT - P17948 VGFR1 Human | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2080 - UNIPROT - P17948 v140 -2011-01-11 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
EX. 2081 - Weissmann 1997 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2082 - Lu 2000 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2083 - Franklin 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2084 - UNIPROT - P35968 VGFR2 Human | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2085 - UNIPROT - P35968 v127 -2011-01-11 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2086 - Bowie 1990 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2087 - US Pub 2006_0058234 A1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2088 - lacono 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2089 - Stewart & Rosenfeld 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2090 - Do 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2091 - Moroney 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2092 - US Pub 2010_0160233 A1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2093 - Hachiya 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2094 - Piques 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2095 - WO 2000_075319 A1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2096 - Kuhlmann 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2097 - Murphy 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2098 - [CONFIDENTIAL] Zaltrap non-comparability | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2099 - Bork 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2100 - Sola 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2101 - [CONFIDENTIAL] Koehler-Stec Report | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2102 - Wells 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2103 - [CONFIDENTIAL] REGN Research Collaboration Agreement Template | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2104 - [CONFIDENTIAL] Marmoset Pregnancy Study Email | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2106 - Macugen Approval Letter | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2107 - 2004 Macugen Label | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2108 - NCT00473330 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2109 - Rosenfeld 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2110 - Genentech Press Release Dec. 30, 2005 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2111 - Genentech Press Release June 30, 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2112 - NCT00473330 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2113 - NCT00473382 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2114 - NCT00486018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2115 - NCT00485836 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2116 - NCT00943072 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2117 - NCT01012973 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2118 - FDA Non-Inferiority Clinical Trials | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2119 - May 2016 Eylea Label | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2120 - Am Acad Opthalmolgy - Sect 9, Chap 6 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2121 - Jaffe 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2122 - [CONFIDENTIAL] VGFT-OD-0605 Analysis Summary | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2123 - NCT00826618 (2009 version) | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2124 - Albini & Davis 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2125 - NCT00826618 (2014 version ) | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2126 - BenEzra 2005 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2127 - Ramirez 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2128 - Adamis Chapter 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2129 - Brown 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2130 - Gragoudas 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2131 - Regillo 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2132 - Levine 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2134 - Regeneron Earnings Call Tr Apr 26, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2135 - Regeneron Earnings Call Tr July 25, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2136 - Eylea Marketing Material, 2013 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2138 - [CONFIDENTIAL] Regeneron Physician ATU Wave 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2139 - Regeneron For the Treatment of Wet AMD, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2140 - [CONFIDENTIAL] Regeneron Physician ATU Wave 5 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2141 - Am. Acad. of Ophthalmol. - Anti-VEGF Treatments | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2142 - Am. Acad. of Ophthalmol. - Bevacizumab | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2143 - Am. Acad. of Ophthalmol. - Ophthalmology Subspecialists | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2144 - Am. Acad. of Ophthalmol. - Retinal Vasculitis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2145 - Am. Acad. of Ophthalmol. - What Is Avastin | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2146 - Am. Acad. of Ophthalmol. - What Is Eylea | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2147 - Am. Acad. of Ophthalmol. - What Is Lucentis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2148 - Am. Soc. of Retina Specialists - About Us | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2149 - Am. Soc. of Retina Specialists - Age-Related Macular Degeneration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2150 - Am. Soc. of Retina Specialists - Branch Retinal Vein Occlusion | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2151 - Am. Soc. of Retina Specialists - Central Retinal Vein Occlusion | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2152 - Am. Soc. of Retina Specialists - Diabetic Retinopathy | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2153 - Amgen - Fusion Protein | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2154 - ASHA - Calculating Medicare Fee Schedule Rates | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2155 - ASPE Issue Brief - Medicare Part B Reimbursement of Prescription Drugs | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2156 - Avastin Drug Label 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2157 - Base Pair Biotechnologies - What is an Aptamer | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2158 - Bausch and Lomb Website - Visudyne | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2159 - Bausch and Lomb Website - Visudyne Saftey Information | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2160 - Bausch Health Companies 10-K, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2161 - Beovu Drug Label Oct. 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2162 - Beovu Drug Label June 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2163 - [CONFIDENTIAL] Regeneron Physician ATU Wave 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2164 - BrightFocus Foundation - AMD Facts & Figures | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2165 - Brookings - Medicare Payment for Physician-Administered (Part B) Drugs | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2166 - Calculator.net - Sample Size Calculator | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2167 - CDC - Vision Loss - A Public Health Problem | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2168 - Centers for Medicare & Medicaid Services Data - Practitioners | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 1 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 2 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 3 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement - Part 4 of 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2170 - [CONFIDENTIAL] US Eylea P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2170 - [REDACTED] US Eylea P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2171 - CloudResearch - Determining Sample Size | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2172 - CMS - 2021 ASP Drug Pricing Files | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2173 - CMS - Medicare Part B Drug Average Sales Price | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2174 - CMS - Physician Fee Schedule | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2175 - CMS Medicare Coverage Database - Billing and Coding Afilbercept | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2176 - [CONFIDENTIAL] Regeneron Q4 Performance Update | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2177 - Donahue 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2178 - Donohue 2004 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2179 - Dreyfuss 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2180 - Miller 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2181 - Drugs.com - Eylea FDA Approval History | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2182 - Elyasi 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2183 - Eye Care Surgery Center - Macular Degeneration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2184 - EyeGuru - Intravitreal Injection Standard Dosing Table | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2185 - Eylea Drug Label Nov. 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2186 - Eylea Drug Label Sept. 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2187 - Eylea Drug Label Oct. 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2188 - Eylea Drug Label May 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2189 - Eylea Drug Label Mar. 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2190 - Eylea Website - Dosing Flexibility for Wet AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2191 - FDA Website - Drug Approval Package Macugen | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2192 - FiercePharma - Beovu, Novartis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2193 - FiercePharma - Novartis Drug Beovu Tied to Potential Vision Loss | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2194 - FiercePharma - The top 20 drugs by worldwide sales in 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2195 - FocusVision - Survey Sample Size How Much Do I Need | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2196 - Gagnon 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2197 - [CONFIDENTIAL] Eylea Physician ATU Benchmark Wave | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2198 - GEN - FDA Green-Lights Genentechs Lucentis | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2199 - Genentech Press Release June 30, 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2200 - [CONFIDENTIAL] Regeneron US Eylea Historical PL | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2200 - [REDACTED] Regeneron US Eylea Historical PL | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2201 - Guha 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2202 - HCPCS Codes - HCPCS Codes | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2203 - Healio - Access to retina providers shows no geographic bias in US | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2204 - Hopkins Medicine Website - Photodynamic Therapy for AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2205 - [CONFIDENTIAL] Eylea DME Market Assessment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2206 - IQVIA 10-K 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2207 - IQVIA - Available IQVIA Data | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2208 - [CONFIDENTIAL] Eylea ATU Wave 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2209 - KFF - A Snapshot of Sources | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2210 - KFF - Medicare Advantage in 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2211 - Ling 2002 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2212 - Lucentis Drug Label 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2213 - Lucentis Drug Label June 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2214 - Lucentis Drug Label Aug. 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2215 - Lucentis Drug Label Apr. 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2216 - Lucentis Drug Label Mar. 2018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2218 - [CONFIDENTIAL] Eylea Components of Reimbursement | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2218 - [REDACTED] Eylea Components of Reimbursement | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2219 - Mankiw Chapter 1 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2220 - Manning 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2221 - Mayo Clinic - Wet macular degeneration - Diagnosis and treatment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2222 - Mayo Clinic - Wet macular degeneration - Symptoms and Causes | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2223 - Medicare Interactive - Medicare Part B Covered Services | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2224 - Medicare Interactive - The parts of Medicare (A, B, C, D) | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2225 - Medicare.gov - Macular Degeneration Coverage | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2226 - Medicare.gov - Medicare Advantage Plans | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2227 - Medicare.gov - When does Medicare coverage start | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2228 - MedlinePlus Medical Encyclopedia - Laser photocoagulation | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2229 - [CONFIDENTIAL] Regeneron WAC Pricing | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2230 - Novartis - Annual Report, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2231 - Novartis Press Release Oct. 8, 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2232 - Novartis Press Release June 11, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2233 - Oct 2012 ASP Pricing File revised 060513 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2234 - Oct 2013 ASP Pricing File updated 060614 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2235 - Oct 2015 ASP Pricing File - updated 120915 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2236 - Oct 2016 ASP Pricing File updated 082817 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2237 - Oct 2017 ASP Pricing File 083017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2238 - Oct 2018 ASP Pricing File updated 052919 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2239 - Oct 2019 ASP Pricing File 052920 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2240 - Oct 2014 ASP Pricing File - revised 090115 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2241 - Oct 2020 ASP Pricing File updated 090121 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2242 - Oct 2021 ASP Pricing File updated 011022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2243 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2244 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2015 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2245 - Pindyck Chapter 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2246 - Regeneron - About Us | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2247 - Regeneron Press Release July 29, 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2248 - Regeneron Press Release Oct. 6, 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2249 - Regeneron Press Release May 13, 2019 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2250 - [CONFIDENTIAL] ASRS Prefernces & Trends Survey 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2251 - Regeneron - History | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2252 - Regeneron Press Release Sept. 21, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2253 - Regeneron - Research Areas | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2254 - Regeneron Form 10-K for 2020 - Part 1 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2254 - Regeneron Form 10-K for 2020 - Part 2 of 2 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2255 - Retinal Physician - Revisiting an Early Treatment for Wet AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2256 - Roche 10-K, 2020 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2257 - Roche Press Release Aug. 13, 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2258 - Roche Press Release Apr. 18, 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2259 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2260 - Schweitzer Chapter 4 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2261 - ScienceDaily - FDA Approves First Angiogenesis Inhibitor | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2262 - Sivaprasad 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2263 - [CONFIDENTIAL] Eylea Sales Summary | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2264 - Verywell Health - Maclular Degeneration Timeline | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2265 - Vestrum Health - Explore what we can do for you | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2266 - Vestrum Health - Pharmaceutical companies | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2267 - Visudyne Drug Label Apr 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2268 - Weidner 2021 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2269 - WHO - Blindness and vision impairment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2270 - Yahoo Finance - Beovu Now Publicly Reimbursed | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2271 - Yorston 2014 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2272 - [CONFIDENTIAL] Eylea Q2 2021 Performance | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2273 - [CONFIDENTIAL] Vestrum Anti-VEGF Category Sales Shares | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2274 - [CONFIDENTIAL] Eylea Wet AMD Line of Therapy Insights | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2275 - [CONFIDENTIAL] Vestrum Anti-VEGF Market Share Adjustment | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2276 - [CONFIDENTIAL] Eylea Q2 2020 Performance | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2277 - [CONFIDENTIAL] Regeneron Marketing Planning Process | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2278 - [CONFIDENTIAL] Regeneron Wave 1 2021 Performance Update | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2279 - Regeneron ATU Sales Share Data - All Indications | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2282 - Regeneron ATU Sales Share Data - CRVO | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2283 - Regeneron ATU Sales Share Data - BRVO | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2284 - Regeneron ATU Sales Share Data - DR without DME | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2285 - [CONFIDENTIAL] Eylea Gross & Net Sales P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2285 - [REDACTED] Eylea Gross & Net Sales P&L | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2286 - Abraham 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2287 - Barbazetto 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2288 - Cruz 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2289 - Retinal Physician Symposium | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2290 - Lucentis Label 2006 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2291 - Schmidt-Erfuth 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2292 - Boyer 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2293 - Margolis 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2294 - Park 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2295 - Spaide 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2296 - Brown 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2297 - Heier 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2298 - [CONFIDENTIAL] Research Agreement | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2299 - [CONFIDENTIAL] VGFT-OD-0605 Protocol Signature Page | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2300 - Eylea P I | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2301 - Regeneron Corrected Press Release Nov. 18, 2011 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2302 - Eylea Approval Letter | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2303 - Bhisitkul & Stewart 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2304 - FDA 22 Case Studies | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2305 - NCT02247531 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2306 - NCT02247479 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2307 - NCT03577899 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2308 - NCT03630952 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2309 - NCT01944839 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2310 - NCT01940900 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2311 - Mathis 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2312 - Cousins 2010 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2313 - Helzner 2007 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2314 - FDA Guidance -Expedited Programs | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2315 - NCT01486771 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2316 - Gallemore 2008 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2317 - Kanghong Press Release - Translation | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2318 - Kanghong Press Release - Chinese | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2319 - Thomas 2013 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2320 - Ohr 2012 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2321 - FDA Approves Eylea for Wet AMD | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2322 - Porter 2018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2323 - Albini Deposition Transcript, Mar. 21, 2023 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2324 - Gerritsen Deposition Transcript, Jan. 14, 2022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2325 - Gerritsen Deposition Transcript, Mar. 17, 2023 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2326 - Albini Depo Ex 14 from Jan. 20, 2022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2327 - Petition for IPR2023-00442 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2328 - Mylan Press Release, Jan. 3, 2018 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2329 - [CONFIDENTIAL] Colyer Declaration 681 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2329 - [REDACTED] Colyer Declaration 681 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2332 - Ophthotech Press Release, Dec. 12, 2016 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2333 - Genentech Press Release, Nov. 9, 2017 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2334 - Ciulla & Rosenfeld 2009 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2335 - US Patent No. 9,669,069 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2336 - US Patent No. 7,374,757 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2337 - US Patent No. 7,070,959 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2338 - Gerritsen Reply Declaration, IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2339 - Gerritsen Declaration, IPR2021-00880 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2340 - Gerritsen Reply Declaration, IPR2021-00880 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2341 - Albini Reply Declaration, IPR2021-00881 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [CONFIDENTIAL] - Hofmann Deposition Transcript, June 23, 2022 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [REDACTED] Hofmann Deposition Transcript, June 23, 2022 - Part 1 of 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [REDACTED] Hofmann Deposition Transcript, June 23, 2022 - Part 2 of 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2342 [REDACTED] Hofmann Deposition Transcript, June 23, 2022 - Part 3 of 3 | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2343 - Spada Declaration | Apr 5, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Unopposed Motion for Entry of Default Protective Order | Apr 3, 2023 | PAPER | PATENT OWNER |
Institution decision and grant of joinder, IPR2023-00532 | Mar 22, 2023 | PAPER | BOARD |
EXPUNGED | Mar 1, 2023 | PAPER | BOARD |
ORDER Granting Patent Owner’s Motion for Admission pro hac vice of Abigail Struthers, Daniel L. Reisner, Jeremy Cobb, Victoria Reines, and Matthew M. Wilk | Mar 1, 2023 | PAPER | BOARD |
Patent Owner's Notice of Deposition of Dr. Thomas A. Albini | Mar 1, 2023 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Mary E. Gerritsen, Ph.D. | Mar 1, 2023 | PAPER | PATENT OWNER |
SCHEDULING ORDER | Feb 8, 2023 | PAPER | BOARD |
Patent Owner's Pro Hac Vice Motion to Admit Abigail Struthers | Feb 6, 2023 | PAPER | PATENT OWNER |
Ex. 2050 - Declaration of Abigail Struthers | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Pro Hac Vice Motion to Admit Daniel Reisner | Feb 6, 2023 | PAPER | PATENT OWNER |
Ex. 2051 - Declaration of Daniel Reisner | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Pro Hac Vice Motion to Admit Jeremy Cobb | Feb 6, 2023 | PAPER | PATENT OWNER |
Ex. 2052 - Declaration of Jeremy Cobb | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Pro Hac Vice Motion to Admit Victoria Reines | Feb 6, 2023 | PAPER | PATENT OWNER |
Ex. 2053 - Declaration of Victoria Reines | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Pro Hac Vice Motion to Admit Matthew Wilk | Feb 6, 2023 | PAPER | PATENT OWNER |
Ex. 2054 - Declaration of Matthew Wilk | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Exhibit List | Feb 6, 2023 | PAPER | PATENT OWNER |
Patent Owner's Power of Attorney | Feb 2, 2023 | PAPER | PATENT OWNER |
Patent Owner's Amended Mandatory Notices | Feb 2, 2023 | PAPER | PATENT OWNER |
Petitioner's Amended Mandatory Notices | Jan 27, 2023 | PAPER | PETITIONER |
Petitioner's Objections to Patent Owner's Exhibits | Jan 26, 2023 | PAPER | PETITIONER |
Patent Owner's Objections to Petitioner's Exhibits | Jan 20, 2023 | PAPER | PATENT OWNER |
Institution Decision: Grant | Jan 11, 2023 | PAPER | BOARD |
Ex. 3001 | Jan 11, 2023 | EXHIBIT | BOARD |
Petitioner's Amended Mandatory Notices | Dec 29, 2022 | PAPER | PETITIONER |
Patent Owner's Sur-Reply to Petitioner's Reply to POPR | Nov 14, 2022 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Nov 14, 2022 | PAPER | PATENT OWNER |
Ex. 2047 - Email from D. Fishman to N. McLaughlin et al | Nov 14, 2022 | EXHIBIT | PATENT OWNER |
Reply to POPR | Nov 7, 2022 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Nov 7, 2022 | PAPER | PETITIONER |
Ex.1103 - Scheduling Order | Nov 7, 2022 | EXHIBIT | PETITIONER |
Ex.1104 - Motion Requesting Expedited Status Conference | Nov 7, 2022 | EXHIBIT | PETITIONER |
Ex.1105 - Regeneron's Stipulation Regarding Case Narrowing and Injunctive Relief | Nov 7, 2022 | EXHIBIT | PETITIONER |
Ex.1106 - Rule 26(f) Joint Report of Parties' Planning Meeting | Nov 7, 2022 | EXHIBIT | PETITIONER |
ORDER Granting Petitioners Motion for Admission Pro Hac Vice of Lauren M. Lesko 37 C.F.R. sec 42.10 | Nov 4, 2022 | PAPER | BOARD |
Preliminary Response of Patent Owner | Oct 13, 2022 | PAPER | PATENT OWNER |
Ex. 2001 - Declaration of Diana V. Do, M.D. | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2002 - CV for Diana V. Do, M.D. | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2007 - Declaration of Rachel Watters | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2008 - Complaint, DI 1 from N.D.W. Va. | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2009 - Response to motion for expedited status conference, DI 26 from N.D.W. Va. | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2010 - District Court Statistics | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2011 - Motion for expedited status conference, DI 7 from N.D.W. Va. | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2012 - Answer, DI 47 from N.D.W. Va. | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2013 - Joint report of planning meeting, DI 75 from N.D.W. Va. | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2018 - Genentech Press Release Dec. 30, 2005 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2019 - Lott 2009 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2020 - Mansour 2009 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2021 - Albini January Deposition Transcript | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2022 - Albini June Deposition Transcript | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2023 - Ohr 2012 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2024 - Shams US Publication 2007_0190058 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2025 - Macugen Drug Label Dec. 2004 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2026 - Albini Reply Declaration REDACTED | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2027 - Patent Owner's Demonstratives for Oral Argument from IPR2021-00880 & -00881 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2028 - Albini Declaration re 069 patent | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2029 - Steinbrook 2006 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2030 - Side-by-side Exclusion Criteria Comparison VIEW vs ANCHOR MARINA | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2031 - Macugen Medical Review | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2032 - Regeneron Press Release Feb. 14, 2013 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2033 - Regeneron Press Release Feb. 6, 2020 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2034 - FiercePharma 2021 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2035 - CDER Statistical Review | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2036 - Brown Deposition Transcript | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2037 - Regeneron ATU Sales Share Data - Wet AMD | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2038 - Regeneron ATU Sales Share Data - DME | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2039 - Eylea Marketing Material Nov. 2013 part 1 of 2 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2039 - Eylea Marketing Material Nov. 2013 part 2 of 2 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2040 - Regeneron Earnings Call Transcript Feb. 13, 2012 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2041 - PUBLIC Hofmann Deposition Transcript part 1 of 3 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2041 - PUBLIC Hofmann Deposition Transcript part 2 of 3 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2041 - PUBLIC Hofmann Deposition Transcript part 3 of 3 | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2042 - Albini Declaration re 338 patent | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2043 - Gerritsen Declaration | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2044 - Gerritsen Deposition Transcript | Oct 13, 2022 | EXHIBIT | PATENT OWNER |
Mylan Updated Power of Attorney | Sep 29, 2022 | PAPER | PETITIONER |
Petitioner's Amended Mandatory Notices | Sep 29, 2022 | PAPER | PETITIONER |
W. Rakoczy Motion for PHV Admission | Sep 29, 2022 | PAPER | PETITIONER |
Ex. 1099 - Declaration in Support of W. Rakoczy PHV Admission | Sep 29, 2022 | EXHIBIT | PETITIONER |
H. Salmen Motion for PHV Admission | Sep 29, 2022 | PAPER | PETITIONER |
Ex. 1100 - Declaration in Support of H. Salmen PHV Admission | Sep 29, 2022 | EXHIBIT | PETITIONER |
E. Hunt Motion for PHV Admission | Sep 29, 2022 | PAPER | PETITIONER |
Ex. 1101 - Declaration in Support of E. Hunt PHV Admission | Sep 29, 2022 | EXHIBIT | PETITIONER |
L. Lesko Motion for PHV Admission | Sep 29, 2022 | PAPER | PETITIONER |
Ex. 1102 - Declaration in Support of L. Lesko PHV Admission | Sep 29, 2022 | EXHIBIT | PETITIONER |
Petitioner's Updated Exhibit List | Sep 29, 2022 | PAPER | PETITIONER |
Petitioner's Amended Mandatory Notices | Aug 23, 2022 | PAPER | PETITIONER |
Patent Owner's Power of Attorney | Aug 8, 2022 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notices | Aug 8, 2022 | PAPER | PATENT OWNER |
Notice: Notice filing date accorded | Jul 13, 2022 | PAPER | BOARD |
Ex 1001 - '681 patent | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1004 - Holash | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1005 - Nguyen-2009 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1006 - Dixon | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1007 - Adis | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1008 - '173 patent | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1009 - '664 patent | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1010 - '758 patent | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1011 - Semeraro | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1012 - Regeneron (28-April-2008) | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1013 - Regeneron (8-May-2008) | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1014 - NCT-795 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1015 - NCT-377 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1016 - IPR2021-00881 Ex.1109 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1017 - '681 FH | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1018 - Heier-2012 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1019 - IPR2021-00881 Ex. 2051 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1020 - Heier-2009 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1021 - 2009 10-Q | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1022 - IPR2021-00881 Ex.1110 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1023 - '959 FH, 12-22-2011 PTE | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1024 - '758 FH, 12-22-2011 PTE | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1025 - Engelbert-2010 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1026 - Rudge-2007 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1027 - Spaide | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1028 - IPR2021-00881 Ex. 2080 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1029 - Gomez-Manzano | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1030 - Mitchell | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1031 - Quiram | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1032 - Bayer (8-May-2008) | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1033 - Dix | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1034 - Fung | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1035 - Lalwani | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1036 - Fraser | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1037 - Lucentis MR | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1038 - Albini CV | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1039 - '095 patent | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1040 - Heimann-2007 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1041 - Regeneron (26-February-2009) | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1042 - NIH AMD | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1043 - Brown | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1044 - NIH DR | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1045 - Ferrara-1999 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1046 - Ferrara-2005 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1047 - Bashshur | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1048 - Lucentis | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1049 - Spielberg | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1050 - Eylea MR | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1051 - Keane | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1052 - Rudge | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1053 - Regeneron (27-March-2007) | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1054 - Regeneron (2-August-2007) | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1055 - Retina Society Meeting Presentation | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1056 - Regeneron (28-September-2008) | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1057 - Jager-2004 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1058 - Rosenfeld-2006 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1059 - Christensen | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1060 - Mueller | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1061 - Gerritsen CV | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1062 - EP-325 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1063 - EP-325-FH | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1064 - Wayback-BJO-Online First | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1065 - BJO-Article Metrics | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1066 - EP-285 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1067 - EP-285-FH | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1068 - Regeneron (14-September-2009) | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1069 - Background-ClinicalTrials.gov | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1070 - Wayback-Affidavit | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1071 - '338 patent | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1072 - Reichert | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1073 - Anderson | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1074 - Ciulla | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1075 - Ni | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1076 - Zarbin | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1077 - Corporate Finance Institute | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1078 - Schneider | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1079 - Kuepper | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1080 - Zucchi | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1081 - Hayes | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1082 - Wilhelmus-1988 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1084 - IPR2021-00881 Ex. 2055 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1085 - IPR2021-00881 Ex. 2050 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1086 - IPR2021-00881 Ex. 2098 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1087 - AA Alignment vs 758 and 959 patents | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1088 - Nguyen-2006 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1089 - Regeneron (19-August-2008) | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1090 - IPR2021-00881 Ex. 2103 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1091 - Rudge-2008 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1092 - AA Alignment vs 758 and 173 patents | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1093 - NA Alignment vs 758 and 173 patents | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1094 - Kim | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1095 - '338 FH | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1096 - '601 patent | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1097 - Monthly-Dosing-Patents | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1098 - IPR2021-00881 Ex.2003 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1083 - Wirbelauer-2006 | Jul 1, 2022 | EXHIBIT | PETITIONER |
Power of Attorney | Jul 1, 2022 | PAPER | PETITIONER |
Ex 1003 - Gerritsen | Jul 1, 2022 | EXHIBIT | PETITIONER |
Ex 1002 - Albini | Jul 1, 2022 | EXHIBIT | PETITIONER |
Petition | Jul 1, 2022 | PAPER | PETITIONER |